[Form 4] Delek US Holdings, Inc. Insider Trading Activity

Delek US Holdings, Inc. (DK) – Form 4 insider transaction Executive Vice President, Special Projects, Reuven Spiegel reported the sale of 700 common shares on 07 July 2025 at $24.00 per share.

Rhea-AI Filing Summary

Delek US Holdings, Inc. (DK) – Form 4 insider transaction

Executive Vice President, Special Projects, Reuven Spiegel reported the sale of 700 common shares on 07 July 2025 at $24.00 per share. The disposition was executed pursuant to a Rule 10b5-1 trading plan adopted 06 Mar 2025, which provides an affirmative defense against allegations of opportunistic trading.

After the transaction, Spiegel’s direct ownership stands at 52,929 shares. No derivative security activity was reported.

• Transaction code: S (open-market sale)
• Percentage of holdings sold: ≈1.3% of reported direct stake
• Filing signed on: 09 Jul 2025

The event represents a modest insider sale of limited size relative to total ownership and was pre-scheduled, reducing interpretative weight. No other material corporate, operational, or financial data accompany this filing.

Insights

Securities Analyst

TL;DR: Minor pre-planned insider sale; neutral impact on DK valuation.

The 700-share sale (~$16.8k) is immaterial to Delek’s market cap and only trims Spiegel’s stake by roughly 1.3%. Because the trade falls under a previously adopted Rule 10b5-1 plan, the risk of negative signaling is limited. Investors typically monitor cumulative insider patterns; in isolation, this transaction does not alter the investment thesis or indicate strategic shifts. I view it as routine, informational, and not valuation-relevant.

Insider Trade Summary

Net Seller: 700 shares

Net Sell 1 txn

Insider Spiegel Reuven

Role EVP, Special Projects

Sold 700 shs ($17K)

Type	Security	Shares	Price	Value
Sale	Common Stock	700	$24.00	$17K

Holdings After Transaction: Common Stock — 52,929 shares (Direct)

Footnotes (1)

1. F1. This transaction for the sale of 700 shares at a price of $24.00 per share was made pursuant to a 10b5-1 plan adopted on March 6, 2025, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/09/2025 - 09:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Spiegel Reuven

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Special Projects

3. Date of Earliest Transaction (Month/Day/Year)
07/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/07/2025		S(1)		700	D	$24	52,929	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction for the sale of 700 shares at a price of $24.00 per share was made pursuant to a 10b5-1 plan adopted on March 6, 2025, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Remarks:

	/s/ Misty Foy, Attorney in Fact	07/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.